Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Julia R. Brown Insider Profile
4 Followers
Julia R. Brown, Director at Statera BioPharma, holds 116.48K shares in Statera BioPharma (Ticker: STAB), holds 7.83K shares in Albireo Pharma (Ticker: ALBO), holds 16.00K shares in Gyre Therapeutics (Ticker: GYRE).
Julia R. Brown has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Julia R. Brown holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Julia R. Brown
Julia R. Brown's Trading History
Statera BioPharma
Jan 12, 2015
Director
Uninformative Buy
18.75K
$1.16K
Albireo Pharma
―
―
―
$345.83K
Gyre Therapeutics
Dec 12, 2014
Director
Uninformative Buy
―
$245.12K
List of latest transactions for each holding click on a transaction to see Julia R. Brown's performance on stock
You May Also Like
Julia R. Brown insider profile FAQ
What is the percentage of profitable transactions made by Julia R. Brown?
The percentage of profitable transactions made by Julia R. Brown is ―.
What is the average return per transaction made by Julia R. Brown?
The average return per transaction made by Julia R. Brown is ―.
What stocks does Julia R. Brown hold?
Julia R. Brown holds: STAB, ALBO, GYRE stocks.
What was Julia R. Brown’s latest transaction?
Julia R. Brown latest transaction was an Uninformative Buy of $18.75K.
What was Julia R. Brown's most profitable transaction?
Julia R. Brown’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Julia R. Brown's role in Statera BioPharma?
Julia R. Brown's role in Statera BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.